The #NuCrew had a blast participating in Bio-Ball 2024 to support Special Olympics Massachusetts — and we’re already practicing for next year’s tournament! 🏀
Nuvalent, Inc.
Biotechnology Research
Cambridge, Massachusetts 4,333 followers
#PreciselyTargetedTherapies for patients with cancer
About us
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
- Website
-
https://www.nuvalent.com/
External link for Nuvalent, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
- Founded
- 2017
Locations
-
Primary
Get directions
One Broadway 14th Floor
Cambridge, Massachusetts 02142, US
Employees at Nuvalent, Inc.
Updates
-
#NuCrewOutings in New York! 😎 What a great opportunity to celebrate everything we’ve achieved as a team, cheers to the amazing journey ahead! $NUVL #biotech #oncology
-
-
📣 The #NuCrew is hiring! We are on the lookout for a Director, Clinical Operations Excellence and Compliance! 👀 Learn more about this role and other new opportunities here: https://lnkd.in/ehFYXCJe #NuTalent #hiring #biotech
-
-
HOT JOB ALERT 🚨Senior Accountant🚨 Interested in joining the #NuCrew? Learn more about this role and other new opportunities here: https://lnkd.in/egUVzzZT #NuTalent #hiring #biotech
-
-
The #NuCrew is ready! We have our game faces on and look forward to meeting everyone on the court! 🏀
No Chemistry S2 Episode 4 On our last episode of season two of No Chemistry, we introduce the final four remaining teams of 2024 Bio-Ball - Sanofi/Shrewsbury, 2seventy bio/Wareham, Nuvalent, Inc./Whitney Academy, and a mystery team/Hockomock Huskies. Mail Time: How do I make sure that my biotech company raises enough money to get to the Garden? Fundraise, fundraise, FUNDRAISE! The challenge ends when the last CEO attempts a free throw basket. See you Friday! Special Olympics Massachusetts Gregg Beloff Steve Huftalen #bioball Alcyone Therapeutics Inc. Alnylam Pharmaceuticals Apellis Pharmaceuticals Blueprint Medicines BlueRock Therapeutics Flagship Pioneering Kelonia Therapeutics Nimbus Therapeutics Sage Therapeutics Seres Therapeutics Tome Biosciences Third Rock Ventures Commonwealth Financial Group
-
Between conferences and team outings, the #NuCrew has kept busy this spring! 🌸
-
-
🎉 Earlier this week, the #NuCrew was back in NYC to ring the Nasdaq opening bell in celebration of all we have accomplished as a team! We are incredibly proud of what we have built together and look forward to all that is to come as we work toward our mission of creating 𝘱𝘳𝘦𝘤𝘪𝘴𝘦𝘭𝘺 targeted therapies for patients with cancer. Congratulations, team! $NUVL #biotech #oncology
🌟 Nuvalent, Inc. was created with the aim to design, develop, and deliver precisely targeted therapies for patients with cancer. 🎉 Today, we're celebrating the incredible momentum the #NuCrew has generated since its IPO in 2021 with 3 novel drug candidates, 2 ongoing Phase 2 clinical trials, and a team that is 100 strong and growing. 👏 We're proud to be your exchange partner and are excited to support your continued success. #NasdaqListed #Nuvalent #biotech #oncology
-
-
🏙 Join us in NYC at the Jefferies Global Healthcare Conference where our CEO James Porter and CFO Alex Balcom, MBA, CPA will participate in a fireside chat on Wednesday, June 5th, 2024, at 4:30 p.m. ET. The recording of the webcast will be available on our website for 30 days. https://lnkd.in/eDe68FxC $NUVL #biotech #oncology
-